ABSTRACT
Background Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterised by hyperglycaemia, impaired lipid metabolism, and insulin resistance. In addition to the traditional risk factors, recent studies have suggested that adipose tissue-derived hormones such as Leptin play a crucial role in the pathogenesis of T2DM and its related complications. However, the exact mechanism underlying the relationship between serum leptin levels and these comorbidities remains unclear.
Methods and Materials The study included 222 individuals, with 74 having T2DM and obesity, and 74 having T2DM without obesity and 74 control group. Serum levels of leptin, total cholesterol, triglycerides, high-density lipoprotein (HDL), low-density lipoprotein (LDL), and HbA1c were measured, and the glomerular filtration rate (GFR) was used as a measure of renal function.
Results Serum leptin levels were significantly higher in individuals with T2DM and obesity compared to those without obesity (p<0.05). Additionally, total cholesterol, triglycerides, and LDL were significantly higher in individuals with T2DM and obesity compared to those without obesity (p<0.05). Serum leptin levels were positively correlated with total cholesterol, triglycerides, and LDL (p<0.05) and negatively correlated with HDL (p<0.01). The GFR was not significant when both groups were compared.
Conclusion Obesity has a negative impact on lipid profile and glycemic control in type 2 diabetes patients and highlights the significance of considering the effect of obesity on the relationship between leptin and lipid profile in diabetic patients. These findings suggest that targeting obesity and leptin levels may be an effective strategy for improving lipid profile and glycemic control in type 2 diabetes.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The Olabisi Onabanjo University Teaching Hospital's Health Research Ethics Committee evaluated and approved the study, and all individuals provided written informed consent following a description of the method.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All data produced in the present work are contained in the manuscript
List of Abbreviations
- BMI
- Body Mass Index
- WHR
- Waist hip ratio
- S.D
- standard deviation
- TCHOL
- Total CholesterolCholesterol
- TRIG
- Triglyceride
- HDL
- high-density lipoprotein
- LDL
- low-density lipoprotein
- HBA1C
- Glycated haemoglobin
- FPG
- Fasting Plasma Glucose
- eGFR
- Estimated Glomerular Filtration rate
- CREAT
- Creatinine
